Abeona Therapeutics Enters Agreement for $30 Million Private Placement

• Abeona Therapeutics announced a private placement agreement on November 9, 2026, expected to raise $30 million before fees and expenses.
• The placement includes 6,400,000 shares of common stock at $3.75 per share.
• Pre-funded warrants cover up to 1,600,043 shares of common stock at a purchase price of $3.7499 per pre-funded warrant.
• Net proceeds will fund general corporate purposes, including pipeline development and ZEVASKYN commercialization efforts.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abeona Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-050606), on November 09, 2026, and is solely responsible for the information contained therein.